EMHTF News and Press, Emerald Health Therapeutics From 08/12/22

Vancouver, British Columbia--(Newsfile Corp. - August 12, 2022) - Emerald Health Therapeutics, Inc. (CSE: EMH) (OTCQB: EMHTF) ("Emerald" or the "Company") is providing an update and additional background on its transaction (the "Transaction") with Skye Bioscience Inc. (OTCQB: SKYE) ("Skye...

Vancouver, British Columbia--(Newsfile Corp. - August 12, 2022) - Emerald Health Therapeutics, Inc. (CSE: EMH) (OTCQB: EMHTF) ("Emerald" or the "Company") announces that it has identified matters which require the Company to make restatements (the "Restatements") in respect of its interim cons...

Group of Shareholders Oppose Plan of Arrangement Between Emerald Health Therapeutics and Skye Biosciences Inc. Canada NewsWire MONTREAL , Aug. 4, 2022 /CNW Telbec/ - Certain shareholders (the " Opposing Shareholders ") of Emerald Health Therapeuti...

Vancouver, British Columbia--(Newsfile Corp. - July 12, 2022) - Emerald Health Therapeutics, Inc. ("Emerald" or the "Company") (CSE: EMH) (OTCQB: EMHTF) reports that it has received an Order of the British Columbia Securities Commission ("BCSC") revoking the management cease trade order ("MCTO...

Emerald Health Therapeutics press release ( OTCQX:EMHTF ): Q1 GAAP EPS of -C$0.02. Revenue of C$3.04M (+14.7% Y/Y) Cash and cash equivalents of C$16.15M For further details see: Emerald Health Therapeutics GAAP EPS of -C$0.02, revenue of C$3.04M

Vancouver, British Columbia--(Newsfile Corp. - July 11, 2022) - Emerald Health Therapeutics, Inc. (CSE: EMH) (OTCQB: EMHTF) ("Emerald" or the "Company") has reported financial results for the quarter ended March 31, 2021. Through the first quarter of 2022 the Company continued to execute on ...

On Monday, Canadian-based Emerald Health Therapeutics, Inc. (CSE: EMH) (OTCQB: EMHTF)  reported its financial results for the year ended December 31, 2021, and gave an update on its plans to exit the cannabis industry. Total revenue for Emerald Health in 2021 fell to ...

Emerald Health Therapeutics press release ( OTCQX:EMHTF ): FY GAAP EPS of -C$0.19. Revenue of C$11.9M (-16.5% Y/Y). For further details see: Emerald Health Therapeutics GAAP EPS of -C$0.19, revenue of C$11.9M

Company also provides bi-weekly MCTO status update Vancouver, British Columbia--(Newsfile Corp. - July 4, 2022) - Emerald Health Therapeutics, Inc. (CSE: EMH) (OTCQB: EMHTF)  ("Emerald" or the "Company") has reported financial results for the year ended December 31, 2021, and an update o...

Vancouver, British Columbia--(Newsfile Corp. - June 16, 2022) - Emerald Health Therapeutics, Inc. (CSE: EMH) (OTCQB: EMHTF) ("Emerald" or the "Company") is providing a default status report in accordance with the alternative information guidelines set out in National Policy 12-203 - Managemen...